Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience. Issue 3 (13th November 2012)
- Record Type:
- Journal Article
- Title:
- Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience. Issue 3 (13th November 2012)
- Main Title:
- Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience
- Authors:
- Nougaret, Stephanie
Fujii, Shinya
Addley, Helen C.
Bibeau, Frederic
Pandey, Himanshu
Mikhael, Hisham
Reinhold, Caroline
Azria, David
Rouanet, Philippe
Gallix, Benoit - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jmri23905-sec-0001" sec-type="section"> <title>Purpose:</title> <p>To evaluate rectal cancer volumetry in predicting initial neoadjuvant chemotherapy response.</p> </sec> <sec id="jmri23905-sec-0002" sec-type="section"> <title>Materials and Methods:</title> <p>Sixteen consecutive patients who underwent neoadjuvant chemotherapy (CX) before chemoradiotherapy (CRT) and surgery were enrolled in this retrospective study. Tumor volume was evaluated at the first magnetic resonance imaging (MRI), after CX and after CRT. Tumor volume regression (TVR) and downstaging were compared with histological results according to Tumor Regression Grade (TRG) to assess CX and CRT response, respectively.</p> </sec> <sec id="jmri23905-sec-0003" sec-type="section"> <title>Results:</title> <p>The mean tumor volume was 132 cm<sup>3</sup> ± 166 before and 56 cm<sup>3</sup> ± 71 after CX. TVR after CX was significantly different between patients with poor histologic response (TRG1/2) and those with good histologic response (TRG3/4) (<italic>P</italic> = 0.001). An optimal cutoff of TVR &gt;68% (area under the curve [AUC]: 0.9, 95% confidence interval [CI]: 0.65–0.98, <italic>P</italic> = 0.0001) to predict good histology response after CX was assessed by receiver operating characteristic curve. According to previous data and this study, we defined 70% as the best cutoff values according to sensitivity (86%),<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jmri23905-sec-0001" sec-type="section"> <title>Purpose:</title> <p>To evaluate rectal cancer volumetry in predicting initial neoadjuvant chemotherapy response.</p> </sec> <sec id="jmri23905-sec-0002" sec-type="section"> <title>Materials and Methods:</title> <p>Sixteen consecutive patients who underwent neoadjuvant chemotherapy (CX) before chemoradiotherapy (CRT) and surgery were enrolled in this retrospective study. Tumor volume was evaluated at the first magnetic resonance imaging (MRI), after CX and after CRT. Tumor volume regression (TVR) and downstaging were compared with histological results according to Tumor Regression Grade (TRG) to assess CX and CRT response, respectively.</p> </sec> <sec id="jmri23905-sec-0003" sec-type="section"> <title>Results:</title> <p>The mean tumor volume was 132 cm<sup>3</sup> ± 166 before and 56 cm<sup>3</sup> ± 71 after CX. TVR after CX was significantly different between patients with poor histologic response (TRG1/2) and those with good histologic response (TRG3/4) (<italic>P</italic> = 0.001). An optimal cutoff of TVR &gt;68% (area under the curve [AUC]: 0.9, 95% confidence interval [CI]: 0.65–0.98, <italic>P</italic> = 0.0001) to predict good histology response after CX was assessed by receiver operating characteristic curve. According to previous data and this study, we defined 70% as the best cutoff values according to sensitivity (86%), specificity (100%) of TVR for predicting good histology response. In contradistinction, MRI downstaging was associated with TRG only after CRT (<italic>P</italic> = 0.04).</p> </sec> <sec id="jmri23905-sec-0004" sec-type="section"> <title>Conclusion:</title> <p>Our pilot study showed that MRI volumetry can predict early histological response after CX and before CRT. MRI volumetry could help the clinician to distinguish early responders in order to aid appropriate individually tailored therapies. <bold>J. Magn. Reson. Imaging 2013;38:726–732. © 2012 Wiley Periodicals, Inc.</bold></p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of magnetic resonance imaging. Volume 38:Issue 3(2013)
- Journal:
- Journal of magnetic resonance imaging
- Issue:
- Volume 38:Issue 3(2013)
- Issue Display:
- Volume 38, Issue 3 (2013)
- Year:
- 2013
- Volume:
- 38
- Issue:
- 3
- Issue Sort Value:
- 2013-0038-0003-0000
- Page Start:
- 726
- Page End:
- 732
- Publication Date:
- 2012-11-13
- Subjects:
- Magnetic resonance imaging -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1522-2586 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jmri.23905 ↗
- Languages:
- English
- ISSNs:
- 1053-1807
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5010.791000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3018.xml